627 related articles for article (PubMed ID: 26871891)
1. Mechanisms and biomaterials in pH-responsive tumour targeted drug delivery: A review.
Kanamala M; Wilson WR; Yang M; Palmer BD; Wu Z
Biomaterials; 2016 Apr; 85():152-67. PubMed ID: 26871891
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of drug release in pH-sensitive micelles for tumour targeted drug delivery system: A review.
Wang Z; Deng X; Ding J; Zhou W; Zheng X; Tang G
Int J Pharm; 2018 Jan; 535(1-2):253-260. PubMed ID: 29113804
[TBL] [Abstract][Full Text] [Related]
3. Nanostructures for pH-sensitive Drug Delivery and Magnetic Resonance Contrast Enhancement Systems.
Sun X; Zhang G; Wu Z
Curr Med Chem; 2018; 25(25):3036-3057. PubMed ID: 28393692
[TBL] [Abstract][Full Text] [Related]
4. pH-sensitive nano-systems for drug delivery in cancer therapy.
Liu J; Huang Y; Kumar A; Tan A; Jin S; Mozhi A; Liang XJ
Biotechnol Adv; 2014; 32(4):693-710. PubMed ID: 24309541
[TBL] [Abstract][Full Text] [Related]
5. pH-sensitive drug-delivery systems for tumor targeting.
He X; Li J; An S; Jiang C
Ther Deliv; 2013 Dec; 4(12):1499-510. PubMed ID: 24304248
[TBL] [Abstract][Full Text] [Related]
6. Functional block copolymer assemblies responsive to tumor and intracellular microenvironments for site-specific drug delivery and enhanced imaging performance.
Ge Z; Liu S
Chem Soc Rev; 2013 Sep; 42(17):7289-325. PubMed ID: 23549663
[TBL] [Abstract][Full Text] [Related]
7. Nanotechnology applied to overcome tumor drug resistance.
Gao Z; Zhang L; Sun Y
J Control Release; 2012 Aug; 162(1):45-55. PubMed ID: 22698943
[TBL] [Abstract][Full Text] [Related]
8. Smart Drug Delivery Systems in Cancer Therapy.
Unsoy G; Gunduz U
Curr Drug Targets; 2018 Feb; 19(3):202-212. PubMed ID: 27033191
[TBL] [Abstract][Full Text] [Related]
9. A smart drug delivery system from charge-conversion polymer-drug conjugate for enhancing tumor therapy and tunable drug release.
Huang H; Li Y; Sa Z; Sun Y; Wang Y; Wang J
Macromol Biosci; 2014 Apr; 14(4):485-90. PubMed ID: 24733784
[TBL] [Abstract][Full Text] [Related]
10. pH-responsive drug-delivery systems.
Zhu YJ; Chen F
Chem Asian J; 2015 Feb; 10(2):284-305. PubMed ID: 25303435
[TBL] [Abstract][Full Text] [Related]
11. pH-Sensitive Biomaterials for Drug Delivery.
Zhuo S; Zhang F; Yu J; Zhang X; Yang G; Liu X
Molecules; 2020 Nov; 25(23):. PubMed ID: 33266162
[TBL] [Abstract][Full Text] [Related]
12. Advancements in pH-responsive nanocarriers: enhancing drug delivery for tumor therapy.
Chen Z; Wang X; Zhao N; Chen H; Guo G
Expert Opin Drug Deliv; 2023; 20(11):1623-1642. PubMed ID: 38059646
[TBL] [Abstract][Full Text] [Related]
13. Prevention of microbial biofilms - the contribution of micro and nanostructured materials.
Grumezescu AM; Chifiriuc CM
Curr Med Chem; 2014; 21(29):3311. PubMed ID: 24606506
[TBL] [Abstract][Full Text] [Related]
14. Targeted therapy for cancer using pH-responsive nanocarrier systems.
Manchun S; Dass CR; Sriamornsak P
Life Sci; 2012 Mar; 90(11-12):381-7. PubMed ID: 22326503
[TBL] [Abstract][Full Text] [Related]
15. Endogenous pH-responsive nanoparticles with programmable size changes for targeted tumor therapy and imaging applications.
Wu W; Luo L; Wang Y; Wu Q; Dai HB; Li JS; Durkan C; Wang N; Wang GX
Theranostics; 2018; 8(11):3038-3058. PubMed ID: 29896301
[TBL] [Abstract][Full Text] [Related]
16. Classification of stimuli-responsive polymers as anticancer drug delivery systems.
Taghizadeh B; Taranejoo S; Monemian SA; Salehi Moghaddam Z; Daliri K; Derakhshankhah H; Derakhshani Z
Drug Deliv; 2015 Feb; 22(2):145-55. PubMed ID: 24547737
[TBL] [Abstract][Full Text] [Related]
17. Stimuli-responsive nanoscale drug delivery systems for cancer therapy.
Li L; Yang WW; Xu DG
J Drug Target; 2019 Apr; 27(4):423-433. PubMed ID: 30173577
[TBL] [Abstract][Full Text] [Related]
18. A critical review on the dissemination of PH and stimuli-responsive polymeric nanoparticular systems to improve drug delivery in cancer therapy.
Bhattacharya S; Prajapati BG; Singh S
Crit Rev Oncol Hematol; 2023 May; 185():103961. PubMed ID: 36921781
[TBL] [Abstract][Full Text] [Related]
19. Reversal of multidrug resistance by stimuli-responsive drug delivery systems for therapy of tumor.
Yin Q; Shen J; Zhang Z; Yu H; Li Y
Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1699-715. PubMed ID: 23611952
[TBL] [Abstract][Full Text] [Related]
20. Tumor extracellular acidity-activated nanoparticles as drug delivery systems for enhanced cancer therapy.
Du JZ; Mao CQ; Yuan YY; Yang XZ; Wang J
Biotechnol Adv; 2014; 32(4):789-803. PubMed ID: 23933109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
